Asthma — UKMLA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Use low-dose ICS/formoterol MART
E is correct. NICE NG245 advises starting low-dose maintenance and reliever therapy for a newly diagnosed person aged 12 or over who is highly symptomatic, such as with regular nocturnal waking. MART uses an ICS/formoterol inhaler for scheduled maintenance and as-needed relief, providing anti-inflammatory treatment whenever reliever doses are used. SABA-only treatment and LABA monotherapy are unsafe because they omit adequate inhaled corticosteroid protection. Long-term oral corticosteroids and leukotriene-receptor-antagonist monotherapy are not the initial strategy. Inhaler technique, adherence, triggers and a personalised action plan must also be addressed.
Reference: NICE NG245, recommendation 1.7.2: https://www.nice.org.uk/guidance/ng245/chapter/recommendations